First Report on Real-World Outcomes with Evoked Compound Action Potential (ECAP)-Controlled Closed-Loop Spinal Cord Stimulation for Treatment of Chronic Pain

ConclusionsThese initial ‘real-world’ data on ECAP-controlled, closed-loop SCS in a real-world clinical setting appear to be promising, as they provide novel insights of the beneficial effect of ECAP-controlled, closed-loop SCS in a real-world setting. The presented results demonstrate a noteworthy maintenance of pain r elief over 12 months and corroborate the outcomes observed in the AVALON prospective, multicenter, single-arm study and the EVOKE double-blind, multicenter, randomized controlled trial.Trial RegistrationThe data collection is registered on the International Clinical Trials Registry Platform (Trial NL7889).

http://link.springer.com/10.1007/s40122-023-00540-y

Source: Pain and Therapy - July 23, 2023 Category: Anesthesiology Source Type: research